Showing results (201-210 of 224) with videos related to

Sort By:
Pageof 23
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 2, 2023
Natural deletion of mouse carboxylesterases Ces1c/d/e impacts drug metabolism and metabolic syndrome developmentChangpei Gan, Jing Wang, Yaogeng Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2017
A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavirVincent A de Weger, Frederik E Stuurman, Jeroen J M A Hendrikx, et al.
British Journal of Cancer|April 21, 2017
Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicityDidier Meulendijks, Linda M Henricks, Bart A W Jacobs, et al.
Anti-Cancer Drugs|May 2, 2002
Clinical pharmacology of the novel marine-derived anticancer agent Ecteinascidin 743 administered as a 1- and 3-h infusion in a phase I studyCharlotte van Kesteren, Chris Twelves, Angela Bowman, et al.
Oncotarget|October 6, 2017
Intraductal cisplatin treatment in a BRCA-associated breast cancer mouse model attenuates tumor development but leads to systemic tumors in aged female miceJolien S de Groot, Paul J van Diest, Miranda van Amersfoort, et al.
Clinical Pharmacology and Therapeutics|October 21, 2021
Effects of the Moderate CYP3A4 Inhibitor Erythromycin on the Pharmacokinetics of Palbociclib: A Randomized Crossover Trial in Patients With Breast CancerLaura Molenaar-Kuijsten, C Louwrens Braal, Stefanie L Groenland, et al.
JCO Precision Oncology|June 8, 2026
Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant AlleleNiels Heersche, Jonathan E Knikman, Maarten J Deenen, et al.
Clinical Pharmacology in Drug Development|October 6, 2020
A Phase 1 Dose-Escalation Study of Low-Dose Metronomic Treatment With Novel Oral Paclitaxel Formulations in Combination With Ritonavir in Patients With Advanced Solid TumorsVincent A de Weger, Marit A C Vermunt, Frederik E Stuurman, et al.
Cancer Chemotherapy and Pharmacology|April 11, 2020
Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancerSanne C F A Huijberts, Robin M J M van Geel, Emilie M J van Brummelen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2019
A Phase I Dose Escalation Study of Once-Weekly Oral Administration of Docetaxel as ModraDoc001 Capsule or ModraDoc006 Tablet in Combination with RitonavirVincent A de Weger, Frederik E Stuurman, Stijn L W Koolen, et al.
Pageof 23